PolarityTE — Investor Presentation (June 2017)
22 slides from PolarityTE's investor presentation, Jun 29, 2017
Slide 1: PolarityTE: Welcome to the Shift
PolarityTE™, Inc. 615 Arapeen Drive, Suite 102 Salt Lake City, UT 84108 www.PolarityTE.com [email protected] (385) 237-2365 y or - on EEE
Slide 2: Forward Looking Statements
WwW ooking Statemen FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy
Slide 3: Opportunity, Technology, Strategy, Pipeline, Team
_ { OPPORTUNITY ya Clinical stage regenerative medicine company with a platform technology in development to create ieee functional tissue, beginning with regenerated skin that grows all layers, glands, and hair TECHNOLOGICAL ADVANTAGE ( a ~ Autologous tissue with its stem cell niche and supporting
Slide 4: Management Team
Denver Lough, MD, PhD Chairman, President, CEO, Chief Scientific Officer Former Resident in Plastic and Reconstructive Surgery at Johns Hopkins + Inventor of PolarityTE Technological Platform + Resigned from Hopkins to Launch PolarityTE + Stanford University, Georgetown University School of Medicine
Slide 5: The PolarityTEAM — Board of Directors
The PolarityTEAM — Board of Directo Denver Lough, MD, PD steve Gorin Jon Mogford, PRD Chairman, President, CEO, Chief Scientific Offer Director Director Former Resident in Plastic and Reconstructive + Regenerative Medicine and Biotech Pioneer: Vice Chancellor for Research, Texat AGM University Sytem
Slide 6: Global Regenerative Medicine and Wound Care Markets
Global Regenerative Medicine and und Care Markets ® Current markets remain untapped with redundant products Growth in Worldwide Prevalence of Wound Types, 2011 -2020 and no autologous (patient’s own tissue/cells) tissue engineering aan 200.000 ® The global market for tissue engineering is expected t
Slide 7: Competitive Landscape
Competitive Landscape A Massive Market Saturated with Stagnant Products Lacking SkinTE Fundamental Principles and Building Blocks for True Functional Skin Regeneration Cellular Full Thic Architecture and Cellular n Cells Autologous Full ™ (inDeveiopment) PolarityTE’ Thickness Skin Integra Bilayer In
Slide 8: Current Therapies: Limitations
urrent Therapies: Limitations ® No Cells: Acellular scaffolds lack the innate ability to regenerate tissue and rely on surrounding tissue in-growth and ultimately secondary skin grafts for definitive coverage we. * Allogeneic/Xenogeneic Cells: Another person’s cells or animal cells will always rejec
Slide 9: The PolarityTE Platform Technology
The PolarityTE™ Platform Technology Discovered through careful observation of tissue regeneration in real-time, the PolarityTE™ Platform Technology has proved its regenerative capacity in preclinical models in SKIN, bone, es a i Vessels/Capillaries muscle, fat, cartilage, nerve, blood —_ = vessels,
Slide 10: The PolarityTE Advantage
The PolarityTE Advanta 2 Autologous: The immune system is highly complex and evolved to recognize anything that : : isn’t “self”. Our foundation is built on using autologous tissue, avoiding allogeneic tissue J te rejection and foreign body reactions. Autologous tissue immediately removes 99% of the
Slide 11: Development Pipeline
Development Pipeline artTE Qe > a
Slide 12: The PolarityTE Launch Product in Development
The PolarityTE Launch Product in Developme Using our platform technology, we aim to regenerate full-thickness, fully functional skin. The process we are developing should allow a patient's own skin to be fully expanded from a small biopsy, and then regenerate ALL LAYERS (epidermis & dermis), hair an
Slide 13: The PolarityTE Launch Product in Development
The PolarityTE Launch Product in Developme World's First: PolarityTE™ Develops Full:thickness Hair-Bearing Skin for Treatment of Burns, Wounds and Scars Deployment of SkinTE™ into Burns, Wounds and Scars Results in Progressive Regenerative Healing of Full-ti ss Functionally Polarized Skin
Slide 14: The PolarityTE Launch Product in Development — SkinTE
e PolarityTE Launch Product in Development — SkinTE Control Wound Progression of Regenerative Full-thickness Healing
Slide 15: The PolarityTE Launch Product in Development — SkinTE
The PolarityTE Launch Product in Developmen inTE Progression of Regenerative Full-thickness Healing
Slide 16: The PolarityTE Launch Product in Development — SkinTE
The PolarityTE Launch Product in Development — SkinTE™
Slide 17: Manufacturing Optimization
Manufecturing Optimization ial in Cranial Defects
Slide 18: Burn Market Commercialization Strategy
Burn Market Commercialization Strate ® National Landscape: 126 burn centers nationwide, creating a straightforward scale-up plan ® Key Decision Makers: Burn Center treatments dictated by Burn Center Directors ® Leaders in the Field on PolarityTE Team: Chief Clinical Officer Dr. Stephen Milner, Forme
Slide 19: Capital Structure
Capital Structure Converted Options Common Stock Pe PolarityTE Common Stock 5,788,365, ‘ Preferred Stock m= =NASDAQ: COOL San Cat www.PolarityTE.com Series B 801,820 Series C 467,787 Series D 44,445 Series E 7,050,000 Stock Options 2,976,512 Total 976,512
Slide 20: Summary of regenerative medicine platform and milestones
® Aregenerative medicine company with a revolutionary proprietary platform technology developing products to regenerate fully functional tissue across a wide spectrum of tissues — skin, bone, muscle, cartilage, nerve, liver, and more The proprietary platform technology provides a springboard for rep
Slide 21: Slide 21
Slide 22: Thank You
Thank You PolarityTE™, Inc. NASDAQ: COOL 615 Arapeen Drive Salt Lake City, UT 84108 (385) 237-2365 www.PolarityTE.com [email protected]